CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82 | -99.9% | 3,645 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | 0.0% | 3,770 | +1.7% | 0.00% | -33.3% |
| Q2 2022 | $84,000 | -23.6% | 3,706 | -25.6% | 0.00% | +200.0% |
| Q1 2022 | $110,000 | +307.4% | 4,984 | +297.8% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,253 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +525.0% | 1,153 | +639.1% | 0.00% | – |
| Q2 2021 | $4,000 | – | 156 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 275 | -68.6% | 0.00% | – |
| Q3 2018 | $12,000 | +140.0% | 876 | +172.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |